Related Experiment Video
Updated: Aug 7, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
Low level lead and inhibition of erythrocyte pyrimidine nucleotidase
1Department of Pediatrics, University of Nebraska Medical Center, Omaha.
Insights
Pyrimidine 5'-nucleotidase (P5N) levels in red blood cells decrease with rising blood lead exposure in children and rats. This enzyme may serve as a sensitive biomarker for early lead poisoning detection.
Area of Science:
- Biochemistry
- Toxicology
- Pediatrics
Background:
- Lead exposure is a significant public health concern, particularly in young children.
- Sensitive biomarkers are needed for early detection of lead toxicity.
- Pyrimidine 5 omino-nucleotidase (P5N) is an enzyme involved in nucleotide metabolism.
Purpose of the Study:
- To investigate the potential of red blood cell Pyrimidine 5 omino-nucleotidase (P5N) as a sensitive biomarker for low-level lead exposure.
- To establish the correlation between blood lead levels and P5N activity in both children and rats.
Main Methods:
- Assessed P5N activity in red blood cells of children aged 2-5 years with varying blood lead levels.
- Administered lead acetate to rats and monitored blood lead levels and P5N activity over 24 days.
- Analyzed the correlation between blood lead concentrations and P5N activity, controlling for reticulocyte count.
Main Results:
- A significant negative linear correlation was observed between blood lead levels and red cell P5N activity in children (r = -0.60, P < 0.01).
- In rats, P5N activity decreased significantly with increasing blood lead levels (r = -0.85, P < 0.001), showing a similar trend to humans.
- Lead exposure did not significantly alter hexokinase, hemoglobin, or red cell count at the measured levels.
Conclusions:
- Red blood cell Pyrimidine 5 omino-nucleotidase (P5N) is a sensitive indicator of lead exposure, even at low levels.
- P5N activity can be a valuable biomarker for early detection and monitoring of lead toxicity in both pediatric and animal models.
- Further research can explore P5N's utility in clinical settings for lead poisoning surveillance.
Abstract:
Pyrimidine 5'-nucleotidase (P5N, EC 3.1.3.5) appears to be a sensitive index of exposure to low level lead. In 21 children 2 to 5 years old with blood leads of 7 to 80 micrograms/dl there was a negative linear correlation of blood lead and red cell P5N: r = -0.60 (P less than 0.01), Y = -0.11X + 12.3. In rats, the enzyme assay was quantitatively similar to that of the human. A treatment group of 12 rats received lead acetate, 36 mg/kg/day, of lead as 0.17 M lead acetate for 24 days. The blood lead of treated rats increased from the control value of 8.3 +/- 1.3 to 36.0 +/- 0.5 on day 24; P5N decreased from 18.3 +/- 0.8 units to 9.0 +/- 1.0 and was below control values at a blood lead of 25. There was a significant negative linear correlation of blood lead and P5N: r = -0.85; n = 17; P less than 0.001; Y = 0.34X + 20.9 that was independent of the correlationship with the reticulocytes. At these levels of blood lead and P5N there was no significant change in the hexokinase, hemoglobin or red cell count and no evidence of stippling.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Erythropoiesis
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Biosynthesis of Nucleic Acids
Antiprotozoal Agents

